Abstract
A 3D-QSAR study has been performed using Self-organizing molecular field analysis (SOMFA) on a novel class of pyridazine analogues as non-competitive and reversible inhibitors of PTP 1B. SOMFA is a novel 3D-QSAR methodology, similar to both comparative molecular field analysis (CoMFA) and molecular similarity studies. SOMFA studies have been performed to correlate chemical structures of pyridazine analogues with their observed PTP 1B inhibitory activity. The master grid obtained for the various SOMFA models indicates electrostatic and shape potential contributions. These can be mapped back onto the structural features relating to trends in activities of the molecules. On the basis of the spatial arrangement of the various shape and electrostatic potential contributions, new inhibitors of PTP 1B can be designed with improved spectrum of activity for the management of type 2 diabetes.
Keywords: Insulin, NIDDM, PTP 1B, Pyridazine, 3D-QSAR, SOMFA
Letters in Drug Design & Discovery
Title: Self-Organizing Molecular Field Analysis on Pyridazine Analogues as Protein Tyrosine Phosphatase 1B (PTP 1B) Inhibitors
Volume: 7 Issue: 6
Author(s): Suresh Thareja, Saurabh Aggarwal, Tilak Raj Bhardwaj and Manoj Kumar
Affiliation:
Keywords: Insulin, NIDDM, PTP 1B, Pyridazine, 3D-QSAR, SOMFA
Abstract: A 3D-QSAR study has been performed using Self-organizing molecular field analysis (SOMFA) on a novel class of pyridazine analogues as non-competitive and reversible inhibitors of PTP 1B. SOMFA is a novel 3D-QSAR methodology, similar to both comparative molecular field analysis (CoMFA) and molecular similarity studies. SOMFA studies have been performed to correlate chemical structures of pyridazine analogues with their observed PTP 1B inhibitory activity. The master grid obtained for the various SOMFA models indicates electrostatic and shape potential contributions. These can be mapped back onto the structural features relating to trends in activities of the molecules. On the basis of the spatial arrangement of the various shape and electrostatic potential contributions, new inhibitors of PTP 1B can be designed with improved spectrum of activity for the management of type 2 diabetes.
Export Options
About this article
Cite this article as:
Thareja Suresh, Aggarwal Saurabh, Raj Bhardwaj Tilak and Kumar Manoj, Self-Organizing Molecular Field Analysis on Pyridazine Analogues as Protein Tyrosine Phosphatase 1B (PTP 1B) Inhibitors, Letters in Drug Design & Discovery 2010; 7 (6) . https://dx.doi.org/10.2174/157018010791306605
DOI https://dx.doi.org/10.2174/157018010791306605 |
Print ISSN 1570-1808 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-628X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Plant-Derived Biomolecules and Drug Delivery Systems in the Treatment of Liver and Kidney Diseases
Current Pharmaceutical Design Structure - Function Analysis of Peptide Analogs of SQSPA with Respect to α-glucosidase and α-amylase Inhibition
Protein & Peptide Letters Non-Demented Individuals with Alzheimer’s Disease Neuropathology: Resistance to Cognitive Decline May Reveal New Treatment Strategies
Current Pharmaceutical Design P2Y Purinoceptors as Potential Emerging Therapeutical Target in Vascular Disease
Current Pharmaceutical Design Molecular Basis of Antiretroviral Drugs-Associated Long-Term Toxicity: How Bad can Good Drugs Be?
Current Medicinal Chemistry - Anti-Infective Agents The Problem of Atrial Fibrillation in Patients with Chronic Kidney Disease
Current Vascular Pharmacology Autoantibodies for Cardiac Channels and Sudden Cardiac Death and its Relationship to Autoimmune Disorders
Current Cardiology Reviews Statins in the Treatment of Acute Ischemic Stroke
Current Pharmaceutical Biotechnology Patent Selections
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery Molecular Mechanisms of Skeletal Muscle Insulin Resistance in Type 2 Diabetes
Current Diabetes Reviews VEGF in the Muscular Layer of Placental Blood Vessels: Immuno- Expression in Preeclampsia and Intrauterine Growth Restrictrion and its Association with the Antioxidant Status
Cardiovascular & Hematological Agents in Medicinal Chemistry Biology of Circulating Nucleic Acids and Possible Roles in Diagnosis and Treatment in Diabetes and Cancer
Infectious Disorders - Drug Targets Antidiabetic Drugs as Antihypertensives: New Data on the Horizon
Current Vascular Pharmacology Modification Strategies of Lipid-Based Nanocarriers for Mucosal Drug Delivery
Current Pharmaceutical Design Chronic Kidney Disease and Cardiovascular Disease: Is there Any Relationship?
Current Cardiology Reviews Cardiac Biomarkers in the Identification of Future Risk in Chronic Obstructive Pulmonary Disease
Current Topics in Medicinal Chemistry Meet Our Editorial Board Member:
Applied Clinical Research, Clinical Trials and Regulatory Affairs Molecular and Biological Functions of Melatonin in Endometrial Cancer
Current Drug Targets An Update in Incretin-Based Therapy: A Focus on Dipeptidyl Peptidase - 4 Inhibitors
Current Diabetes Reviews Potential metabolic and behavioural roles of the putative endocannabinoid receptors GPR18, GPR55 and GPR119 in feeding
Current Neuropharmacology